Literature DB >> 18004968

Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension.

Steven E Feldon1.   

Abstract

OBJECT: The object of this study was to compare surgical techniques for management of visual loss in idiopathic intracranial hypertension (IIH) unresponsive to medical treatment.
METHODS: The published literature was reviewed using electronic and manual search techniques. Articles were categorized based upon the surgical procedure performed, including optic nerve sheath decompression (ONSD), also called optic nerve sheath fenestration; intracranial venous sinus stent placement; ventriculoperitoneal (VP) shunt placement; and lumboperitoneal (LP) shunt placement. Demographic data and visual outcome of the cumulative experience were compiled and compared for each type of surgical intervention.
RESULTS: Seventeen patients treated by stent placement, 31 by VP shunt placement, 44 by LP shunt placement, and 252 patients by ONSD were identified in the literature; average follow-up ranged from 11.8 months for patients treated with stents to 57.2 months for those treated with LP shunts. Improved or resolved vision deficit was noted in 38.7% of patients after VP shunt placement, 47% of patients after stent placement, 44.6% of patients after LP shunt placement, and 80% of eyes after ONSD. Visual worsening was rare for all procedures evaluated.
CONCLUSIONS: There is a paucity of information regarding visual outcomes from intracranial venous stent placement and cerebrospinal fluid diversion procedures. Visual outcomes from ONSD are better documented and appear to be superior to other surgical techniques for management of IIH. Further studies with improved data collection regarding visual outcomes are needed for surgical procedures other than ONSD in order to assess their possible value as treatments for visual loss in IIH.

Entities:  

Mesh:

Year:  2007        PMID: 18004968     DOI: 10.3171/FOC-07/11/E6

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  14 in total

1.  Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension.

Authors:  S J Hickman; N Raoof; H Panesar; J M McMullan; I M Pepper; B Sharrack
Journal:  Neuroophthalmology       Date:  2014-11-12

Review 2.  Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension.

Authors:  Sarah R Ahmad; Heather E Moss
Journal:  Semin Neurol       Date:  2019-12-17       Impact factor: 3.420

Review 3.  Update on Idiopathic Intracranial Hypertension.

Authors:  Sivashakthi Kanagalingam; Prem S Subramanian
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.598

4.  Long-Term Results of Optic Nerve Sheath Fenestration for Idiopathic Intracranial Hypertension: Earlier Intervention Favours Improved Outcomes.

Authors:  Stacy L Pineles; Nicholas J Volpe
Journal:  Neuroophthalmology       Date:  2013-01-29

5.  Dural venous sinus stenting for medically and surgically refractory idiopathic intracranial hypertension.

Authors:  Sudhakar R Satti; Lakshmi Leishangthem; Alejandro Spiotta; M Imran Chaudry
Journal:  Interv Neuroradiol       Date:  2017-01-10       Impact factor: 1.610

Review 6.  Update on the surgical management of idiopathic intracranial hypertension.

Authors:  Nisha Mukherjee; M Tariq Bhatti
Journal:  Curr Neurol Neurosci Rep       Date:  2014-03       Impact factor: 5.081

7.  Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension.

Authors:  M Bussière; R Falero; D Nicolle; A Proulx; V Patel; D Pelz
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-26       Impact factor: 3.825

Review 8.  [Treatment of idiopathic intracranial hypertension by endovascular improvement of venous drainage of the brain].

Authors:  M Aguilar-Pérez; H Henkes
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

9.  [Indications and technique of optic nerve sheath fenestration].

Authors:  W A Lagrèze
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

Review 10.  Pseudotumor cerebri: an update on treatment options.

Authors:  Sarita B Dave; Prem S Subramanian
Journal:  Indian J Ophthalmol       Date:  2014-10       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.